B7-H3-targeted affibody radioligand probe

· Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for B7-H3-targeted affibody radioligand probe, covering 2024-08-23 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors [EARLY_Phase 1]